[Should hepatitis C be screened? Socioeconomic analysis of different screening strategies for chronic hepatitis C in French population].
Rotily
M
M
INSERM U 379, Institut Paoli-Calmettes, Marseille.
Loubière
S
S
Nixon
J
J
Bourlière
M
M
Halfon
P
P
Moatti
J P
JP
D000410:Alanine Transaminase / Q000097:blood; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D003663:Decision Trees; D004797:Enzyme-Linked Immunosorbent Assay; D005602:France; D006526:Hepatitis C / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D015151:Immunoblotting; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D012959:Socioeconomic Factors
D000410:Alanine Transaminase
Faut-il dépister l'hépatite C? Analyse socio(-)économique de différentes stratégies de dépistage de l'hépatite chronique C dans la population française.